Skip to main content

AbbVie

AbbVie is an American biopharmaceutical company created in 2013 following its corporate separation from Abbott Laboratories. The company researches, manufactures, and markets biological and small-molecule pharmaceuticals in therapeutic areas including immunology, oncology, neuroscience, eye care, and medical aesthetics. Key commercial products within its portfolio include Humira, Skyrizi, Rinvoq, Imbruvica, and Botox treatments. Revenue drivers consist primarily of wholesale sales of patented biopharmaceutical treatments to healthcare distributors, pharmacy networks, and medical institutions globally. AbbVie ranks among the world's highest-revenue biopharmaceutical firms with extensive commercial operations across international healthcare markets. The enterprise is headquartered in North Chicago, Illinois, and traded on the New York Stock Exchange under the ticker symbol ABBV.

138 of the funds FundTelligence covers report a position in AbbVie.

Sector
Health Care
Country
United States
Funds holding it
138
Exposure themes
Multiple, Reproductive health, Treatment, Women's Health

Funds holding AbbVie

Showing the 8 largest of 138 funds holding it.

Loading...